Life Sciences and Biotechnology

Kalorama Information’s latest report, The Market and Potential for Molecular Point of Care (mPOC), 2021, provides comprehensive market sizing, forecasting, trend mapping, and competitive analysis for point of care (POC) tests using PCR or other molecular technologies. Designed for near-patient settings, these tests offer fast turnaround times. Major in vitro diagnostic (IVD) companies such as…

Explore the comprehensive analysis of the POC testing market, its growth prospects, and the key players driving innovation in this essential segment of the healthcare industry in Kalorama Information’s report, The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 8th Edition.

By the middle of the decade, the global point-of-care (POC) testing market is expected to…

The genetic involvement in the pathogenesis of neurological diseases is profound, with central nervous system disorders accounting for about 60 percent of the 6,400 phenotypic entries in cataloged inherited human diseases. Neurological diseases, especially brain diseases, represent the final frontier in medical discovery. Advances in testing, such as next-generation sequencing (NGS), have been instrumental in…

Sepsis poses one of the greatest challenges in healthcare today, with approximately 1.7 million cases and 270,000 deaths annually in the United States alone. The condition is the most expensive to treat in US hospitals, highlighting the urgent need for effective diagnosis and treatment solutions. Kalorama Information’s report, Sepsis Diagnostics Products and Market Trends, provides…

This report provides an in-depth and up-to-date look into scientists’ use of the genome editing tool, CRISPR/Cas9. Our survey reveals that while the market is growing steadily, there are challenges confronting suppliers. For instance, Bioinformatics found that over a quarter of scientist respondents said they were highly or somewhat likely to switch away from their primary brand…

The Worldwide Market for Laboratory-Developed Tests (LDTs), 2nd Edition provides a comprehensive analysis of the global sequencing market. This report covers market trends, challenges, strategies, and detailed profiles of key companies and products. It includes precise market share estimates and revenue growth forecasts, offering insights into the competitive landscape, including major deals and product developments.…

Urgent care centers (UCCs) are a vital and growing segment of the U.S. healthcare system, with around 10,000 locations nationwide. They offer walk-in care, a broad range of services, extended hours, and minimal wait times. Kalorama Information’s report, The U.S. Market for Urgent Care Centers (Including COVID-19, POC Tests, Vaccines and Other Sales), 2^nd Edition,…

We’ve Spoken To Your Customers

Understanding the overall customer experience, from pre-purchase experience, to product experience, to post-purchase experience, is more important now than ever before. Customer experience offers an opportunity for suppliers to differentiate themselves from other suppliers in a crowded life science marketplace on something more than product performance and price. An excellent…

Outsourcing drug discovery represents the initial phase of the drug development process. By outsourcing segments of their drug discovery programs, pharmaceutical and biotechnology companies have discovered a cost-effective strategy that enhances hit-to-lead conversion and early identification of ineffective compounds. Outsourcing accelerates the drug discovery process, transforming the industry from low-end research services to high-value, sophisticated…

What is the size of the cell and gene therapy market? According to Cell Therapy and Gene Therapy Markets, 2020 from Kalorama Information, the global market for cell and gene therapy in 2020 is estimated to reach $3.9 billion, with most of the market focused on the treatment of cancer. This exciting period in the…

Description:

The past few years have seen extraordinary advances in artificial intelligence (AI) in clinical medicine. More products have been cleared for clinical use, more new research-use-only applications have come to market, and many more are in development. In recent years, diagnostics companies, in collaboration with AI companies, have begun implementing increasingly sophisticated machine learning…

First published by BioInformatics in 2003, Advertising to Life Scientists is the indispensable guide to reaching your scientific audience. Improve the effectiveness of your advertising by understanding the messages and media that scientists consider most useful and appropriate.

This report explores the preferences, opinions, and impact of print and digital advertising on life scientists. This report provides…